Latest filing published 09 May 2019 for AMAG PHARMACEUTICALS INC., €49k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Elizabeth Scott Bolgiano: trading record in brief
Elizabeth Scott Bolgiano discloses dealings in AMAG Pharmaceuticals Inc. to SEC (Form 4). Between 2 March 2018 and 9 May 2019, the trades on record add up to 9 filings.
Every open-market trade on record is a purchase: 1 purchase worth €49k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 8 share grants. So far in 2019, the count stands at 1 purchase and no sales.
The newest entry dates from 9 May 2019: an open-market purchase of €49k, in AMAG Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Elizabeth Scott Bolgiano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$10.9361.4% of flowCommon StockSEC:0000792977-19-000087:0Canonical exit: 7 Aug 2019 (T+90)
- 696 shares@ US$14.7611.4% of flowCommon StockSEC:0000792977-19-000045:0
- 931 shares@ US$14.7615.2% of flowCommon StockSEC:0000792977-19-000045:1
- 7,500 sharesCommon StockSEC:0000792977-19-000033:0
- 7,500 sharesCommon StockSEC:0000792977-19-000033:1
- 695 shares@ US$15.5112.0% of flowCommon StockSEC:0000792977-19-000020:0
- 9,000 sharesCommon StockSEC:0001179110-18-003691:0
- 9,000 sharesCommon StockSEC:0001179110-18-003691:1
- 3,549 shares@ US$21.0043.4% of flowCommon StockSEC:0001179110-18-003691:2
9 of 9 declarations
